Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
The daily traffic congestion along the streets and interstate lanes of Chattanooga could be headed the way of the horse and buggy with help from ORNL researchers.
Diego Del-Castillo-Negrete, a distinguished staff member in the Fusion Energy Division, was cited for Outstanding Technical Achievement – National Laboratory. He will be recognized during the GMiS annual conference, which will be held virtually Oct. 11-22. The HENAAC awards program is in its 33rd year.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
Joseph Pickel has been elected a 2021 fellow of the American Chemical Society, or ACS. Pickel supports the Fusion and Fission Energy and Sciences Directorate as environment, safety and health
As a metabolic engineer at Oak Ridge National Laboratory, Adam Guss modifies microbes to perform the diverse processes needed to make sustainable biofuels and bioproducts.
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
In a step toward increasing the cost-effectiveness of renewable biofuels and bioproducts, scientists at ORNL discovered a microbial enzyme that degrades tough-to-break bonds in lignin, a waste product of biorefineries.
As rising global temperatures alter ecosystems worldwide, the need to accurately simulate complex environmental processes under evolving conditions is more urgent than ever.
Kathy McCarthy, associate laboratory director for Fusion and Fission Energy and Science at the Department of Energy’s Oak Ridge National Laboratory, has been elected fellow of the American Nuclear Society for her nationally and internationally recognized leadership in nuclear energy and fusion.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.